Abstract
Activation of protein kinase C (PKC) regulates the activity of a number of neurotransmitter transporters. When Xenopus oocytes expressing the cloned human dopamine transporter (hDAT) were pretreated with bath-applied phorbol 12-myristate 13-acetate (PMA), a PKC activator, [3H]DA uptake decreased irreversibly in a time- and dose-dependent manner (IC50 = 22 nM; maximal inhibition = 63–85%). The inhibition appeared to be PKC-specific because incubation with the inactive form of phorbol ester 4α-phorbol-12,13-didecanoate (400 nM) did not change the uptake activity and PMA (100 nM) inhibition could be partially blocked by the selective PKC inhibitor bisindolylmaleimide I (1 μM). Saturation studies of [3H]DA uptake showed that PMA-induced inhibition was due to a decrease in Vmax with no change in KT. Similar to uptake, PMA pretreatment inhibited both the hDAT transport-associated and substrate-independent leak currents. PMA also decreased membrane capacitance (Cm) by 40%, selectively in hDAT-expressing oocytes. In addition, PMA pretreatment resulted in a 77% decrease in Bmax of [3H]mazindol binding to intact oocytes. In contrast, binding to whole homogenates of PMA-pretreated oocytes was not significantly altered. These results suggest that PMA regulates hDAT expressed in Xenopus oocytes by altering cell surface trafficking of hDAT.
Footnotes
-
Send reprint requests to: Dr. Nancy R. Zahniser, Department of Pharmacology C236, University of Colorado Health Sciences Center, 4200 East Ninth Ave., Denver, CO 80262.
-
↵1 This work was supported by National Institutes of Health grant DA04216, postdoctoral fellowship DA50706 to S.J.Z. and career development award DA05706 to N.R.Z.
- Abbreviations:
- BIM
- bisindolylmaleimide I
- Cm,membrane capacitance
- DA, dopamine
- DAT
- dopamine transporter
- DMSO
- dimethyl sulfoxide
- FRB
- frog Ringer’s buffer
- GABA
- γ-aminobutyric acid
- hDAT
- human dopamine transporter
- HEPES
- 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
- I-V
- current-voltage
- 4αPDD
- 4α-phorbol-12,13-didecanoate
- PKA
- cAMP-dependent protein kinase
- PKC
- protein kinase C
- PMA
- phorbol 12-myristate 13-acetate
- rDAT
- rat dopamine transporter
- SDS
- sodium dodecyl sulfate
- SERT
- serotonin transporter
- Received January 29, 1997.
- Accepted May 27, 1997.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|